Epitomee Medical Ltd (TLV:EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 825.00
-12.40 (-1.48%)
Apr 29, 2026, 3:23 PM IDT
Epitomee Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 13.65 | 16.57 | 15.63 | 35.95 | 64.31 | Upgrade
|
| Short-Term Investments | - | 5.51 | 19.16 | 10.18 | - | Upgrade
|
| Cash & Short-Term Investments | 13.65 | 22.08 | 34.79 | 46.13 | 64.31 | Upgrade
|
| Cash Growth | -38.19% | -36.53% | -24.59% | -28.27% | 215.12% | Upgrade
|
| Other Receivables | 0.17 | 0.21 | 0.17 | 0.18 | 0.39 | Upgrade
|
| Receivables | 0.17 | 0.21 | 0.17 | 0.18 | 0.39 | Upgrade
|
| Inventory | 0.47 | 0.02 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.06 | 0.05 | 0.03 | 0.06 | 0.1 | Upgrade
|
| Other Current Assets | 0.05 | 0.13 | 0.07 | 0.13 | 0.04 | Upgrade
|
| Total Current Assets | 14.4 | 22.49 | 35.06 | 46.51 | 64.83 | Upgrade
|
| Property, Plant & Equipment | 18.32 | 17.43 | 4.93 | 8.42 | 1.13 | Upgrade
|
| Other Long-Term Assets | 0.39 | 0.29 | 0.27 | 0.28 | 0.06 | Upgrade
|
| Total Assets | 33.11 | 40.21 | 40.27 | 55.2 | 66.02 | Upgrade
|
| Accounts Payable | 0.31 | 1.09 | 0.54 | 0.31 | 1.14 | Upgrade
|
| Accrued Expenses | 0.8 | 0.82 | 0.96 | 1.37 | 0.99 | Upgrade
|
| Current Portion of Leases | 0.73 | 0.58 | 0.45 | 0.49 | 0.3 | Upgrade
|
| Other Current Liabilities | 0.47 | 0 | 0 | 0 | 0.02 | Upgrade
|
| Total Current Liabilities | 2.31 | 2.5 | 1.96 | 2.16 | 2.45 | Upgrade
|
| Long-Term Leases | 4.83 | 3.76 | 3.51 | 3.6 | 0.28 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 10 | 10 | Upgrade
|
| Total Liabilities | 7.15 | 6.26 | 5.47 | 15.76 | 12.73 | Upgrade
|
| Common Stock | 0.82 | 0.82 | 0.81 | 0.81 | 0.81 | Upgrade
|
| Additional Paid-In Capital | 94.39 | 93.78 | 93.17 | 92.14 | 90.6 | Upgrade
|
| Retained Earnings | -69.63 | -61.02 | -59.56 | -53.87 | -38.48 | Upgrade
|
| Comprehensive Income & Other | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | Upgrade
|
| Total Common Equity | 25.96 | 33.95 | 34.8 | 39.45 | 53.3 | Upgrade
|
| Shareholders' Equity | 25.96 | 33.95 | 34.8 | 39.45 | 53.3 | Upgrade
|
| Total Liabilities & Equity | 33.11 | 40.21 | 40.27 | 55.2 | 66.02 | Upgrade
|
| Total Debt | 5.57 | 4.35 | 3.96 | 4.08 | 0.58 | Upgrade
|
| Net Cash (Debt) | 8.08 | 17.73 | 30.83 | 42.05 | 63.73 | Upgrade
|
| Net Cash Growth | -54.42% | -42.48% | -26.67% | -34.03% | 366.78% | Upgrade
|
| Net Cash Per Share | 0.27 | 0.60 | 1.04 | 1.43 | 36.24 | Upgrade
|
| Filing Date Shares Outstanding | 29.84 | 29.58 | 29.52 | 29.46 | 29.23 | Upgrade
|
| Total Common Shares Outstanding | 29.84 | 29.58 | 29.52 | 29.46 | 29.23 | Upgrade
|
| Working Capital | 12.09 | 19.99 | 33.1 | 44.34 | 62.38 | Upgrade
|
| Book Value Per Share | 0.87 | 1.15 | 1.18 | 1.34 | 1.82 | Upgrade
|
| Tangible Book Value | 25.96 | 33.95 | 34.8 | 39.45 | 53.3 | Upgrade
|
| Tangible Book Value Per Share | 0.87 | 1.15 | 1.18 | 1.34 | 1.82 | Upgrade
|
| Machinery | 11.71 | 10.95 | 1.06 | 3.89 | 1.23 | Upgrade
|
| Leasehold Improvements | 2.84 | 2.73 | 0.18 | 1.18 | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.